Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression

References

• Topstad D, Dickinson JA. Thyroid cancer incidence in Canada: a national cancer registry analysis. CMAJ Open. 2017;5(3):E612–14.
   PubMedGoogle Scholar
• Xu J, Li Z, Su Q, et al. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway. Oncol Rep. 2017;37(3):1555–1564.
   PubMed Web of Science ®Google Scholar
• Jisheng H, Nan Z, Rui K, et al. Sun: total thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region. World J Surg Oncol. 2016;14(1):20.
   PubMedGoogle Scholar
• Zhang P, Ming Y, Ye Q, et al. Comprehensive circRNA expression profile during ischemic postconditioning attenuating hepatic ischemia/reperfusion injury. Sci Rep. 2019;9(1). DOI:10.1038/s41598-018-36443-8
   Google Scholar
• Liu Q, Zhang X, Hu X, et al. Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 ‘Sponge’ in human cartilage degradation. Rep. 2016;6:22572.
   Google Scholar
• Yang K, Wang Y, Zhang F. et al. CircN4BP2L2 promotes colorectal cancer growth and metastasis through regulation of the miR-340-5p/CXCR4 axis. Lab Invest. 2022;102(1):38–47.
   PubMed Web of Science ®Google Scholar
• Man W, Cui, Y, Li, J, et al. circTAB2 inhibits lung cancer proliferation, migration and invasion by sponging miR-3142 to upregulate GLIS2. Apoptosis. 2023;28:471–484.
   PubMed Web of Science ®Google Scholar
• Cui W, Xue J. Circular RNA DOCK1 downregulates microRNA-124 to induce the growth of human thyroid cancer cell lines. Biofactors. 2020;46(4):591–599.
   PubMedGoogle Scholar
• Fan Y, Shi H, Hu Y, et al. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway. J Gene Med. 2020;22(12):e3269.
   PubMed Web of Science ®Google Scholar
• Lan X, Xu J, Chen C, et al. The landscape of circular RNA expression profiles in papillary thyroid carcinoma based on RNA sequencing. Cell Physiol Biochem. 2018;47(3):1122–1132.
   PubMedGoogle Scholar
• Zinovyev A, Morozova N, Gorban AN, et al. Mathematical modeling of microRna–mediated mechanisms of translation repression. Adv Exp Med Biol. 2013;774:189–224.
   Google Scholar
• Wang J, Zeng H, Li H, et al. MicroRNA-101 inhibits growth, proliferation and migration and induces apoptosis of breast cancer cells by targeting sex-determining region Y-Box 2. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2017;43:717.
   PubMedGoogle Scholar
• Saiselet M, Pita JM, Augenlicht A, et al. Maenhaut C: miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers. Oncotarget. 2016;7(32). DOI:10.18632/oncotarget.9655
   PubMedGoogle Scholar
• Huang N, Wu Z, Lin L, et al. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget. 2015;6(17):15222–15234.
   PubMedGoogle Scholar
• Xu H, Zhao L, Fang Q, et al. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. PLoS ONE. 2014;9(12):e115565.
   PubMed Web of Science ®Google Scholar
• Sui GQ, Fei D, Guo F, et al. MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3. Am J Cancer Res. 2017;7(5):1177–1187.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Kanemaru K, Kojima R, et al. Simultaneous loss of phospholipase Cδ1 and phospholipase Cδ3 causes cardiomyocyte apoptosis and cardiomyopathy. Cell Death Amp Dis. 2014;5(5):e1215.
   PubMedGoogle Scholar
• Nakamura Y, Hamada Y, Fujiwara T, et al. Phospholipase C-1 and -3 are essential in the trophoblast for placental development. Molcellbiol. 2005;25(24):10979.
   PubMed Web of Science ®Google Scholar
• Lin L, Wen J, Lin B, et al. Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway. Acta Biochim Biophys Sin (Shanghai). 2021;53(4):481–491.
   PubMed Web of Science ®Google Scholar
• Tian W, Yang XL, Yang H, et al. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway. Cell Death Amp Dis. 2021;12(11):1030.
   PubMed Web of Science ®Google Scholar
• Wang L, Li B, Yi X, et al. Circ_smad4 promotes gastric carcinogenesis by activating wnt/β‐catenin pathway. Cell Proliferation. 2021;54(3):e12981.
   PubMed Web of Science ®Google Scholar
• Shen XM, Tang J, Huang YZ, et al. CircRNF111 contributes to adipocyte differentiation by elevating PPARγ expression via miR-27a-3p. Epigenetics. 2022;18:1–15.
   Web of Science ®Google Scholar
• Wang ZL, Xia FD, Feng TC, et al. Otud6B-AS1 inhibits viability, migration, and invasion of thyroid carcinoma by targeting miR-183-5p and miR-21. Front Endocrinol. 2020;11:136.
   PubMed Web of Science ®Google Scholar
• Li XS, Shen FZ, Huang LY, et al. Jin BZ: lncRNA small nucleolar RNA host gene 20 predicts poor prognosis in glioma and promotes cell proliferation by silencing P21. Onco Targets Ther. 2019;12:805–814.
   PubMed Web of Science ®Google Scholar
• Cheng JL, Li DJ, Lv MY, et al. LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149. Cancer Genet Ther. 2021;28(7–8):850–863.
   PubMed Web of Science ®Google Scholar
• Wang DW, Lou XQ, Liu ZL, et al. LncRNA SNHG1 protects SH-SY5Y cells from hypoxic injury through miR-140-5p/Bcl-XL axis. Int J Neurosci. 2021;131(4):336–345.
   PubMed Web of Science ®Google Scholar
• Plodkowski RA, Lee EJ, Huang MG. Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits. 2015;8(1):30–40.
   PubMedGoogle Scholar
• Barrett SP, Salzman J. Circular RNAs: analysis, expression and potential functions. Development. 2016;143(11):1838–1847.
   PubMed Web of Science ®Google Scholar
• Cai H, Hu B, Ling J, et al. Hsa_circ_0103809 promotes cell proliferation and inhibits apoptosis in hepatocellular carcinoma by targeting miR-490-5p/SOX2 signaling pathway. Am J Transl Res. 2018;10(6):1690–1702.
   PubMed Web of Science ®Google Scholar
• Chu J, Tao L, Yao T, et al. Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression. Cell Death Amp Dis. 2021;12(1):112.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wei W. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell. J Surg Oncol. 2011;104(3):278–283.
   PubMed Web of Science ®Google Scholar
• Minna E, Romeo P, Cecco LD, et al. MiR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget. 2014;5(9):2513–2528.
   PubMedGoogle Scholar
• Long F, Lin Z, Li L, et al. Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer. Mol Cancer. 2021;20(1). DOI:10.1186/s12943-021-01318-6
   Web of Science ®Google Scholar
• Liu L, Wu SQ, Zhu X, et al. Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer. Neoplasma. 2019;66(5):736–745.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Xia FD, Yao L, et al. circSSU72 promotes cell proliferation, migration and invasion of papillary thyroid carcinoma cells by targeting miR-451a/S1PR2 axis. Front Cell Dev Biol. 2022;10:817028.
   PubMed Web of Science ®Google Scholar
• Liu G, Guo W, Rao M, et al. circRNA hsa_circ_104566 sponged miR-338-3p to promote hepatocellular carcinoma progression. Cell Transplant. 2020;29(1):963689720963948.
   PubMedGoogle Scholar
• Qu SB, Yang XS, Li XL, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu T, Li TS, et al. Hsa_circrna_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis. Cancer Genet Ther. 2021;28(3–4):279–293.
   PubMed Web of Science ®Google Scholar